Vismodegib
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1024 publications
Use of Hedgehog Pathway Inhibitors in Combination Therapy for Basal Cell Carcinoma: A Review and Narrative Synthesis.
Journal: The Journal of clinical and aesthetic dermatology
Published: July 22, 2026
Fatal Outcome of Widespread Cranial Basal Cell Carcinoma Due to Intraparenchymal Brain Extension in a Setting of Local Recurrences.
Journal: Cureus
Published: July 14, 2026
Vismodegib Exerts a Pleotropic Effect on Topotecan-Resistant and Sensitive Ovarian Cancer Cell Lines in 2D and 3D Cell Culture Models.
Journal: Molecules (Basel, Switzerland)
Published: May 22, 2026
Biomimetic co-delivery nanoplatform overcomes CAF- and TAM-induced immunosuppression to augment therapeutic efficacy against triple-negative breast cancer.
Journal: International journal of pharmaceutics: X
Published: May 10, 2026
Advanced Basal Cell Carcinoma in a Geriatric Patient: A Case Report and Ethical Considerations.
Journal: Cureus
Published: May 04, 2026
Structure Merging Approach Leads to New Dual Potent and Selective USP25/USP28 Inhibitors.
Journal: Journal of medicinal chemistry
Published: April 22, 2026
Next-Generation Therapies for Meningioma: Overcoming Barriers and Expanding Treatment Options.
Journal: Cancer investigation
Published: April 22, 2026
Precision medicine directed therapy enabling long-term survival in medulloblastoma: a case report.
Journal: Frontiers in oncology
Published: April 14, 2026
Establishment of a patient-derived malignant peripheral nerve sheath tumor organoid model reveals SHH pathway activation and therapeutic vulnerability.
Journal: Human cell
Published: April 13, 2026
Impact of gamma irradiation and ethylene oxide sterilisation on the stability of crystalline and amorphous drug solids.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: April 09, 2026
Last Updated: 09/26/2026